Article Details

Japan approves AstraZeneca's Ultomiris for generalised myasthenia gravis

Retrieved on: 2022-08-26 14:54:54

Tags for this article:

Click the tags to see associated articles and topics

Japan approves AstraZeneca's Ultomiris for generalised myasthenia gravis. View article details on HISWAI: https://pharmaceutical-business-review.com/news/japan-astrazeneca-ultomiris-generalised-myasthenia-gravis/

Excerpt

AstraZeneca has received the Japan's MHLW approval for Ultomiris (ravulizumab) to treat generalised myasthenia gravis (gMG) in adult patients.

Article found on: pharmaceutical-business-review.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up